StevenRoyDavissMDDFAPA
Psychiatry • Columbia, MDAddiction, Psychosomatic Medicine, Clinical Informatics
Medical Director, Optum
Dr. Daviss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10175 Little Patuxent Pkwy
Columbia, MD 21044Phone+1 443-896-0517
Summary
- Maryland-based physician triple-boarded in Psychiatry, Addiction Medicine, and Psychosomatic Medicine, with expertise in the intersection of psychiatry, primary care, health information technology, data science, and healthcare policy. Dr. Daviss is the president of the Maryland-DC Society of Addiction Medicine (MDDCSAM 2021), past president of the Maryland Psychiatric Society (MPS), and is medical director for Optum Maryland, which manages the Maryland Medicaid contract for specialty behavioral health services.
Other recent leadership positions: founding president and CEO of Fuse Health Strategies; lead psychiatrist for Mindoula Health’s Collaborative Care Program; HHS/SAMHSA Senior Medical Advisor to the Office of the Chief Medical Officer; HHS/SAMHSA Medical Director of the Center for Substance Abuse Treatment. Others: URAC; Mooditude; M3 Information; BCMS.
Education & Training
University of Maryland/Sheppard PrattResidency, Psychiatry, 1993 - 1995
UPMC Medical EducationResidency, Psychiatry, 1989 - 1993
University of Maryland School of MedicineClass of 1989
Certifications & Licensure
MD State Medical License 1993 - 2026
OH State Medical License 2019 - 2023
DC State Medical License 2019 - 2022
VA State Medical License 2019 - 2022
FL State Medical License 2019 - 2021- American Board of Psychiatry and Neurology Psychiatry
- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- 153 citationsLocal circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neuronsSteven R. Daviss, David A. Lewis
Psychiatry Research. 1995-11-29 - 38 citationsSeizures and Prolonged QTc With Atomoxetine OverdoseSharad Sawant, Steven R. Daviss
The American Journal of Psychiatry. 2004-04-01 - 4 citationsOrganic anxiety disorder with symptoms of akathisia in a patient treated with the immunosuppressant FK506Lawson Bernstein, Steven R. Daviss
General Hospital Psychiatry. 1992-05-01
Press Mentions
Dr. John V. Prunskis Among 28 Appointed to New HHS Pain Management Best Practices Inter-Agency Task ForceMay 2nd, 2018
Are Today’s EHR Alerts Putting Clinicians, Patients at Risk?July 19th, 2017- How Might Technology Change Mental Health Care?January 27th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
